1 | terms | 16,918 |
2 | favour | 2,289 |
3 | favor | 2,209 |
4 | spite | 1,286 |
5 | lieu | 50 |
6 | reshuffling | 4 |
7 | downregulations | 3 |
8 | furtherance | 3 |
9 | non-rodents | 3 |
10 | prognosing | 3 |
11 | brainstems | 2 |
12 | disfavour | 2 |
13 | economization | 2 |
14 | phosphorylation/inactivation | 2 |
15 | shouguang | 2 |
16 | strategy.date | 2 |
17 | subperiods | 2 |
18 | t2+t3 | 2 |
19 | vivo.journal | 2 |
20 | vulcanization | 2 |
21 | 'weeks | 1 |
22 | 0/1689 | 1 |
23 | 1-ml/kg | 1 |
24 | 139/149 | 1 |
25 | 146/361 | 1 |
26 | 20p.cent | 1 |
27 | 21,126 | 1 |
28 | 3,467 | 1 |
29 | 310/a | 1 |
30 | 3pts | 1 |
31 | 47/249 | 1 |
32 | 50/189 | 1 |
33 | 641/9001 | 1 |
34 | 72/80 | 1 |
35 | 75ml | 1 |
36 | 80p.cent | 1 |
37 | 93/2121 | 1 |
38 | 9α-hydroxylation | 1 |
39 | absentia | 1 |
40 | aggregation/misfolding | 1 |
41 | bio-specimens | 1 |
42 | bio-technique | 1 |
43 | cephalothoraxes | 1 |
44 | chikitsa-sthana | 1 |
45 | colorectums | 1 |
46 | contig512 | 1 |
47 | coupling-decoupling | 1 |
48 | deprtment | 1 |
49 | detraction | 1 |
50 | discission | 1 |
51 | earts | 1 |
52 | eggs/gram | 1 |
53 | exophthalmic | 1 |
54 | extent/intensity | 1 |
55 | eye-spots | 1 |
56 | eyeballs | 1 |
57 | flailing | 1 |
58 | group-viewings | 1 |
59 | hamlets/villages | 1 |
60 | hba1c-value | 1 |
61 | hibitors | 1 |
62 | iiis6 | 1 |
63 | incubates | 1 |
64 | italy.journal | 1 |
65 | knowledge/use | 1 |
66 | ldll-cholesterol | 1 |
67 | leachate/g | 1 |
68 | left-lateralization | 1 |
69 | length/quality | 1 |
70 | limbos | 1 |
71 | livertissues | 1 |
72 | memoriam | 1 |
73 | mice.journal | 1 |
74 | milligrams/kilogram | 1 |
75 | nano/microvolumes | 1 |
76 | neural-anatomy | 1 |
77 | non-purchasers | 1 |
78 | number/patency | 1 |
79 | oases | 1 |
80 | ostias | 1 |
81 | oxiproducts | 1 |
82 | palms/soles | 1 |
83 | patiants | 1 |
84 | pedegrees | 1 |
85 | per-pregnancy | 1 |
86 | picograms/gram | 1 |
87 | proteopathies | 1 |
88 | prvention | 1 |
89 | re-dos | 1 |
90 | regionalisation | 1 |
91 | reliev | 1 |
92 | remittence | 1 |
93 | reviewingthefirst | 1 |
94 | sonicates | 1 |
95 | survivial | 1 |
96 | tex/tin | 1 |
97 | the-levels | 1 |
98 | thediagnosis | 1 |
99 | threeprovinces | 1 |
100 | ton_1032 | 1 |
101 | trasformation | 1 |
102 | two/third | 1 |
103 | unicellulars | 1 |
104 | up-stirring | 1 |
105 | vitro-added | 1 |
106 | voltage-gating | 1 |
107 | whomen | 1 |
108 | wp7 | 1 |
109 | xelox+ | 1 |
110 | α1,3-galactosylation | 1 |
111 | ≥1day | 1 |
1 | 'weeks | 1 |
2 | 0/1689 | 1 |
3 | 1-ml/kg | 1 |
4 | 139/149 | 1 |
5 | 146/361 | 1 |
6 | 20p.cent | 1 |
7 | 21,126 | 1 |
8 | 3,467 | 1 |
9 | 310/a | 1 |
10 | 3pts | 1 |
11 | 47/249 | 1 |
12 | 50/189 | 1 |
13 | 641/9001 | 1 |
14 | 72/80 | 1 |
15 | 75ml | 1 |
16 | 80p.cent | 1 |
17 | 93/2121 | 1 |
18 | 9α-hydroxylation | 1 |
19 | absentia | 1 |
20 | aggregation/misfolding | 1 |
21 | bio-specimens | 1 |
22 | bio-technique | 1 |
23 | brainstems | 2 |
24 | cephalothoraxes | 1 |
25 | chikitsa-sthana | 1 |
26 | colorectums | 1 |
27 | contig512 | 1 |
28 | coupling-decoupling | 1 |
29 | deprtment | 1 |
30 | detraction | 1 |
31 | discission | 1 |
32 | disfavour | 2 |
33 | downregulations | 3 |
34 | earts | 1 |
35 | economization | 2 |
36 | eggs/gram | 1 |
37 | exophthalmic | 1 |
38 | extent/intensity | 1 |
39 | eye-spots | 1 |
40 | eyeballs | 1 |
41 | favor | 2,209 |
42 | favour | 2,289 |
43 | flailing | 1 |
44 | furtherance | 3 |
45 | group-viewings | 1 |
46 | hamlets/villages | 1 |
47 | hba1c-value | 1 |
48 | hibitors | 1 |
49 | iiis6 | 1 |
50 | incubates | 1 |
51 | italy.journal | 1 |
52 | knowledge/use | 1 |
53 | ldll-cholesterol | 1 |
54 | leachate/g | 1 |
55 | left-lateralization | 1 |
56 | length/quality | 1 |
57 | lieu | 50 |
58 | limbos | 1 |
59 | livertissues | 1 |
60 | memoriam | 1 |
61 | mice.journal | 1 |
62 | milligrams/kilogram | 1 |
63 | nano/microvolumes | 1 |
64 | neural-anatomy | 1 |
65 | non-purchasers | 1 |
66 | non-rodents | 3 |
67 | number/patency | 1 |
68 | oases | 1 |
69 | ostias | 1 |
70 | oxiproducts | 1 |
71 | palms/soles | 1 |
72 | patiants | 1 |
73 | pedegrees | 1 |
74 | per-pregnancy | 1 |
75 | phosphorylation/inactivation | 2 |
76 | picograms/gram | 1 |
77 | prognosing | 3 |
78 | proteopathies | 1 |
79 | prvention | 1 |
80 | re-dos | 1 |
81 | regionalisation | 1 |
82 | reliev | 1 |
83 | remittence | 1 |
84 | reshuffling | 4 |
85 | reviewingthefirst | 1 |
86 | shouguang | 2 |
87 | sonicates | 1 |
88 | spite | 1,286 |
89 | strategy.date | 2 |
90 | subperiods | 2 |
91 | survivial | 1 |
92 | t2+t3 | 2 |
93 | terms | 16,918 |
94 | tex/tin | 1 |
95 | the-levels | 1 |
96 | thediagnosis | 1 |
97 | threeprovinces | 1 |
98 | ton_1032 | 1 |
99 | trasformation | 1 |
100 | two/third | 1 |
101 | unicellulars | 1 |
102 | up-stirring | 1 |
103 | vitro-added | 1 |
104 | vivo.journal | 2 |
105 | voltage-gating | 1 |
106 | vulcanization | 2 |
107 | whomen | 1 |
108 | wp7 | 1 |
109 | xelox+ | 1 |
110 | α1,3-galactosylation | 1 |
111 | ≥1day | 1 |
1 | xelox+ | 1 |
2 | 72/80 | 1 |
3 | 641/9001 | 1 |
4 | 93/2121 | 1 |
5 | 146/361 | 1 |
6 | contig512 | 1 |
7 | ton_1032 | 1 |
8 | t2+t3 | 2 |
9 | 21,126 | 1 |
10 | iiis6 | 1 |
11 | 3,467 | 1 |
12 | wp7 | 1 |
13 | 139/149 | 1 |
14 | 47/249 | 1 |
15 | 50/189 | 1 |
16 | 0/1689 | 1 |
17 | 310/a | 1 |
18 | absentia | 1 |
19 | chikitsa-sthana | 1 |
20 | exophthalmic | 1 |
21 | vitro-added | 1 |
22 | two/third | 1 |
23 | furtherance | 3 |
24 | remittence | 1 |
25 | knowledge/use | 1 |
26 | strategy.date | 2 |
27 | spite | 1,286 |
28 | hba1c-value | 1 |
29 | bio-technique | 1 |
30 | leachate/g | 1 |
31 | 1-ml/kg | 1 |
32 | shouguang | 2 |
33 | aggregation/misfolding | 1 |
34 | reshuffling | 4 |
35 | flailing | 1 |
36 | coupling-decoupling | 1 |
37 | up-stirring | 1 |
38 | prognosing | 3 |
39 | voltage-gating | 1 |
40 | survivial | 1 |
41 | mice.journal | 1 |
42 | vivo.journal | 2 |
43 | italy.journal | 1 |
44 | 75ml | 1 |
45 | ldll-cholesterol | 1 |
46 | memoriam | 1 |
47 | eggs/gram | 1 |
48 | picograms/gram | 1 |
49 | milligrams/kilogram | 1 |
50 | whomen | 1 |
51 | tex/tin | 1 |
52 | discission | 1 |
53 | α1,3-galactosylation | 1 |
54 | 9α-hydroxylation | 1 |
55 | trasformation | 1 |
56 | regionalisation | 1 |
57 | phosphorylation/inactivation | 2 |
58 | left-lateralization | 1 |
59 | economization | 2 |
60 | vulcanization | 2 |
61 | detraction | 1 |
62 | prvention | 1 |
63 | favor | 2,209 |
64 | favour | 2,289 |
65 | disfavour | 2 |
66 | ostias | 1 |
67 | subperiods | 2 |
68 | threeprovinces | 1 |
69 | pedegrees | 1 |
70 | hamlets/villages | 1 |
71 | proteopathies | 1 |
72 | palms/soles | 1 |
73 | nano/microvolumes | 1 |
74 | oases | 1 |
75 | incubates | 1 |
76 | sonicates | 1 |
77 | livertissues | 1 |
78 | cephalothoraxes | 1 |
79 | group-viewings | 1 |
80 | thediagnosis | 1 |
81 | 'weeks | 1 |
82 | the-levels | 1 |
83 | eyeballs | 1 |
84 | brainstems | 2 |
85 | terms | 16,918 |
86 | colorectums | 1 |
87 | bio-specimens | 1 |
88 | downregulations | 3 |
89 | limbos | 1 |
90 | re-dos | 1 |
91 | unicellulars | 1 |
92 | non-purchasers | 1 |
93 | hibitors | 1 |
94 | oxiproducts | 1 |
95 | patiants | 1 |
96 | non-rodents | 3 |
97 | eye-spots | 1 |
98 | 3pts | 1 |
99 | earts | 1 |
100 | 20p.cent | 1 |
101 | 80p.cent | 1 |
102 | deprtment | 1 |
103 | reviewingthefirst | 1 |
104 | lieu | 50 |
105 | reliev | 1 |
106 | ≥1day | 1 |
107 | per-pregnancy | 1 |
108 | number/patency | 1 |
109 | neural-anatomy | 1 |
110 | length/quality | 1 |
111 | extent/intensity | 1 |